This is a Validated Antibody Database (VAD) review about mouse Cldn10, based on 4 published articles (read how Labome selects the articles), using Cldn10 antibody in all methods. It is aimed to help Labome visitors find the most suited Cldn10 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cldn10 synonym: 6720456I16Rik; Cldn10a; Cldn10b; D14Ertd728e; claudin-10; claudin 10B; claudin-10A
Invitrogen
rabbit polyclonal |
| In order to ascertain how claudin-6 is associated with MMP-2 activation and cell invasiveness, Invitrogen Cldn10 antibody (Invitrogen, 388400) was used in flow cytometry on human samples at 1:100 (fig 3a). Exp Cell Res (2017) ncbi |
rabbit polyclonal |
| In order to examine the localization of epithelial junctions in relation to paracellular permeability and intestinal adhesion, Invitrogen Cldn10 antibody (Life Technologies, 38-8400) was used in immunohistochemistry - paraffin section on Rhesus monkey samples at 1:200. Exp Toxicol Pathol (2014) ncbi |
rabbit polyclonal |
| In order to evaluate the impact of claudin expression in grade I-III ependymomas, Invitrogen Cldn10 antibody (Zymed, 38-8400) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1d). Histol Histopathol (2013) ncbi |
rabbit polyclonal |
| In order to measure claudins 18 and 10 expression in primary lung carcinomas, Invitrogen Cldn10 antibody (Zymed, 38-8400) was used in immunohistochemistry on human samples (fig 2). Int J Clin Exp Pathol (2011) ncbi |
Articles Reviewed
- Merikallio H, Paakko P, Harju T, Soini Y. Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers. Int J Clin Exp Pathol. 2011;4:667-73 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments